Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel × Prednisone × 1 year × Clear all

Sponsor

Conditions

Prostatic Neoplasms 63 Lymphoma, Large B-Cell, Diffuse 45 Lymphoma 28 Burkitt Lymphoma 27 Precursor Cell Lymphoblastic Leukemia-Lymphoma 20 Lymphoma, Follicular 15 Lymphoma, Non-Hodgkin 13 Lymphoma, B-Cell 12 Neoplasms 11 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8 Multiple Myeloma 8 Lymphoma, T-Cell, Peripheral 8 Lymphoma, B-Cell, Marginal Zone 7 Leukemia 7 Hodgkin Disease 7 Prostatic Neoplasms, Castration-Resistant 6 Leukemia, Lymphocytic, Chronic, B-Cell 6 Neoplasm Metastasis 4 Lymphoma, Mantle-Cell 4 Leukemia, Biphenotypic, Acute 4 Recurrence 3 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3 Ovarian Neoplasms 3 Myasthenia Gravis 3 Metastatic Castration-resistant Prostate Cancer 3 Lymphoproliferative Disorders 3 Lymphoma, Large-Cell, Anaplastic 3 Lymphoma, AIDS-Related 3 Immunoblastic Lymphadenopathy 3 Hematologic Neoplasms 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡